News

CEPI and SK bioscience partner to advance mRNA vaccine technology to build vaccine library, enable rapid response against Disease X

Up to $40 million in funding committed to support development of mRNA-vaccine candidates against Lassa Fever virus and Japanese Encephalitis virus

25 Oct 2022

The Race to Future-Proof Coronavirus Vaccines

To help humanity get ahead, we need vaccines that provide broad protection against new variants of COVID-19 as well as future coronavirus threats.

08 Sep 2022

Could monkeypox give us an R&D blueprint to end pandemics?

Availability of smallpox countermeasures, developed to counter bioterrorism, also give the world the means to combat monkeypox and other Orthopoxviruses. What if this approach could be applied to all viral families?

24 May 2022

CEPI funds NEC Group's broadly protective betacoronavirus vaccine

Up to $4.8m will support using artificial intelligence to develop new vaccine candidates.

11 Apr 2022

The Global Pandemic Preparedness Summit: On the road to a 100-Day vaccine

Global leaders used the Summit to explore how to develop vaccines against future pandemics in just 100 days.

28 Mar 2022

Accelerating diagnostic tests to prevent a future pandemic

FIND are working closely with CEPI to prepare diagnostic tests for future pandemics.

15 Mar 2022

Nipah survivors study to advance new vaccines against highly fatal threat

Nipah remains one of the deadliest infections known to infect humans, however no vaccines are currently licensed for use.

15 Mar 2022

1 2 3 4 5 6